Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)
Sweden
· Delayed Price · Currency is SEK 1.670
+0.155 (10.23%)
Jun 27, 2025, 5:23 PM CET
Scandinavian ChemoTech AB Revenue
Scandinavian ChemoTech AB had revenue of 2.47M SEK in the quarter ending March 31, 2025, with 83.79% growth. This brings the company's revenue in the last twelve months to 7.69M, up 87.04% year-over-year. In the year 2024, Scandinavian ChemoTech AB had annual revenue of 6.57M with 132.67% growth.
Revenue (ttm)
7.69M
Revenue Growth
+87.04%
P/S Ratio
5.25
Revenue / Employee
2.56M
Employees
6
Market Cap
40.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.57M | 3.74M | 132.67% |
| Dec 31, 2023 | 2.82M | 2.35M | 496.62% |
| Dec 31, 2022 | 473.00K | -2.11M | -81.70% |
| Dec 31, 2021 | 2.59M | 1.17M | 82.81% |
| Dec 31, 2020 | 1.41M | -3.24M | -69.63% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.31B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Camurus AB | 2.04B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vimian Group AB | 4.24B |